Zoetis | ZTS - Cost Of Sales

Stock Price
127.42
Daily Change
0.69 0.54%
Monthly
1.39%
Yearly
-25.67%
Q1 Forecast
120.98

Zoetis reported $683M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
AbbVie USD 4.55B 757M Dec/2025
Align Technology USD 363.97M 7.48M Dec/2025
Bayer EUR 4.31B 57M Sep/2025
Bristol-Myers Squibb USD 4.92B 657M Dec/2025
Charles River Laboratories USD 693.46M 20.52M Sep/2025
Dentsply International USD 463M 17M Sep/2025
Eli Lilly USD 3.37B 363.7M Dec/2025
Henry Schein USD 2.38B 93M Sep/2025
Idexx Laboratories USD 432.46M 10.58M Dec/2025
Illumina USD 400M 49M Dec/2025
IQVIA Holdings USD 3.24B 518M Dec/2025
J&J USD 7.97B 689M Dec/2025
Laboratory Of America USD 2.54B 11M Sep/2025
Merck USD 3.32B 531M Dec/2025
Neogen USD 118.01M 3.79M Sep/2025
Pacira USD 48.6M 6.59M Sep/2025
Perrigo USD 666.2M 27.2M Sep/2025
Pfizer USD 6.29B 2.12B Dec/2025
Quest Diagnostics USD 1.91B 49M Sep/2025
Sanofi EUR 4.29B 421M Dec/2025
Sanofi EUR 3.76B 344M Dec/2025
Zoetis USD 683M 3M Sep/2025